CARDINAL HEALTH INC
About CARDINAL HEALTH INC
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $222.6B
- Net income
- $1.6B
- Total assets
- $53.1B
- Market cap
- $48.2B
- Gross margin
- 3.7%
- Operating margin
- 1.0%
- Net margin
- 0.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $222.6B
- Cost of revenue
- $214.4B
- Gross profit
- $8.2B
- Operating expenses
- $5.9B
- Operating income
- $2.3B
- Income tax
- $532.0M
- Net income
- $1.6B
- EPS (basic)
- $6.48
- EPS (diluted)
- $6.45
Balance sheet
- Total assets
- $53.1B
- Current assets
- $36.4B
- Total liabilities
- $55.8B
- Current liabilities
- $38.9B
- Shareholders’ equity
- -$2.6B
Cash flow
- Operating cash flow
- $2.4B
- Investing cash flow
- -$5.6B
- Financing cash flow
- $1.9B
- Net cash flow
- -$1.3B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $48.2B
- P/E ratio
- 31.7
- EPS (diluted)
- $6.45
- Dividend yield
- 1.01%
- Shares outstanding
- 235.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 4, 1983
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $1.6B in FY2025.
- Revenue grew 37% from FY2021 to FY2025.
- Gross margin of 3.7%, net margin 0.7%.
- Trading 11% below its 52-week high.
- Pays a dividend yielding about 1.01% annually.
- Valued at a price-to-earnings (P/E) ratio of 31.7.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CARDINAL HEALTH INC.
Write a review
News about CARDINAL HEALTH INC
News & sentiment via Polygon.io
